Back to ALB overview

Albemarle's lithium pricing rebound restores earnings power while the balance sheet resets

Published August 17, 202621 min read·TickerFile Research · Albemarle Corporation (ALB)

Albemarle, the Charlotte-based producer of lithium and specialty chemicals traded on the New York Stock Exchange under ALB, delivered the strongest quarter since the 2023 lithium boom in the second quarter of 2026, reporting net income attributable to common shareholders of $438 million, or $3.52 per diluted share, on net sales of $1.7 billion that rose 31% from a year earlier. The recovery was driven by a 73% jump in energy storage pricing, with the segment's average realized price climbing to $19.53 per kilogram of lithium carbonate equivalent, a leap from $12.17 in the year-ago quarter, as a rebounding global lithium market lifted the index-referenced contract book that dominates the business. After two brutal years in which collapsing lithium prices pushed the company to the edge of breakeven, this quarter restores the earnings power that underpins the entire equity story.

The mechanism behind the swing is straightforward operating leverage in a business where a large share of cost is fixed and where every incremental dollar of selling price falls mostly to the bottom line. Adjusted EBITDA, which is earnings before interest, taxes, depreciation and amortization and is the metric management and lenders use to measure the company, reached $858 million in the quarter, up 155% year over year, on a consolidated margin of 49%. Energy Storage, the lithium unit, drove the bulk of the improvement with adjusted EBITDA of $723 million, up 229%, while the smaller Specialties unit added $118 million, up 61%, on firmer bromine pricing and modest volume growth. What the market is arguably underappreciating is the structural repair: through the sale of a 51% stake in its Ketjen refining catalysts business in March 2026 and an associated debt tender, the company cut total debt from $3.1 billion at year-end 2025 to $1.9 billion at mid-2026, a deleveraging that, combined with $638 million of free cash flow in the quarter, leaves the balance sheet in its strongest position since the downcycle began.

The load-bearing risk is that the entire thesis rests on lithium prices holding or rising, and Albemarle itself frames its 2026 outlook as a band that swings violently with the market price of the metal. The company's own scenarios for full-year 2026 adjusted EBITDA range from roughly $0.9 billion to $1.0 billion if lithium averages about $10 per kilogram, to $2.4 billion to $2.6 billion at $20, to $4.2 billion to $4.4 billion at $30, a wide range that reveals how much of the equity value sits on a single commodity assumption. The falsifiable clock is the next lithium price data point and the third-quarter print in early November 2026, which tests whether the second-quarter rebound represented a durable up-cycle or a short-lived correction within a still-supplied market. Until the pricing strength proves sustainable, the market is likely to keep the stock priced for reversion rather than for the peak of the scenario band.